Trial Profile
A prospective, observational, single-centre study to evaluate the efficacy of telaprevir on renal function in patients with chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon alfa; Ribavirin
- Indications Hepatitis C
- Focus Pharmacokinetics
- 13 May 2016 New trial record